tm logo
JADE THERAPEUTICS
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 13 Jan 2023

Last Applicant/ Owned by

675 Arapeen Drive, Suite 302

Salt Lake City

UT

841081228

Serial Number

86789139 filed on 15th Oct 2015

Registration Number

4987761 registered on 28th Jun 2016

in the Principal Register

Correspondent Address

MICHAEL B. STEWART

FISHMAN STEWART YAMAGUCHI PLLC

39533 WOODWARD AVENUE, SUITE 250

BLOOMFIELD HILLS, MI 48304

Filing Basis

1. use application currently

Disclaimer

"THERAPEUTICS"

JADE THERAPEUTICS

"THERAPEUTICS" Research and development of products and pharmaceutical preparations in the field of ophthalmology; Scientific, medical and pharmaceutical research and development in the field of ophthalmology; Providing medical and scientific research information in the field ophthalmology

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development of products and pharmaceutical preparations in the field of ophthalmology; Scientific, medical and pharmaceutical research and development in the field of ophthalmology; Providing medical and scientific research information in the field ophthalmology


First Use Date in General

30th Apr 2013

First Use Date in Commerce

30th Apr 2013

Mark Details


Serial Number

No 86789139

Mark Type

No Service Mark

Attorney Docket Number

No 67539-0001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Jan 2023CANCELLED SEC. 8 (6-YR)
28th Jun 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28th Jun 2016REGISTERED-PRINCIPAL REGISTER
12th Apr 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12th Apr 2016PUBLISHED FOR OPPOSITION
23rd Mar 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12th Feb 2016APPROVED FOR PUB - PRINCIPAL REGISTER
12th Feb 2016EXAMINER'S AMENDMENT ENTERED
12th Feb 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12th Feb 2016EXAMINERS AMENDMENT E-MAILED